AMG
IHE icon

Asset Management Group’s iShares US Pharmaceuticals ETF IHE Stock Holding History

Asset Management Group’s Portfolio IHE Stock Details IHE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.29M Buy
12,997
+40
+0.3% +$3.6K 0.19% 86
2026
Q1 		$1.12M Buy
12,957
+44
+0.3% +$3.85K 0.18% 87
2025
Q4 		$1.1M Buy
12,913
+88
+0.7% +$7.02K 0.18% 86
2025
Q3 		$931K Buy
12,825
+56
+0.4% +$3.86K 0.15% 90
2025
Q2 		$837K Buy
12,769
+61
+0.5% +$3.97K 0.15% 91
2025
Q1 		$897K Buy
12,708
+52
+0.4% +$3.61K 0.17% 88
2024
Q4 		$832K Buy
12,656
+40
+0.3% +$2.75K 0.15% 89
2024
Q3 		$891K Buy
12,616
+64
+0.5% +$4.46K 0.16% 90
2024
Q2 		$832K Buy
12,552
+56
+0.4% +$3.67K 0.16% 93
2024
Q1 		$848K Buy
12,496
+46
+0.4% +$3.04K 0.16% 91
2023
Q4 		$769K Buy
12,450
+90
+0.7% +$5.29K 0.15% 90
2023
Q3 		$729K Hold
12,360
– – 0.16% 91
2023
Q2 		$738K Buy
12,360
+39
+0.3% +$2.32K 0.16% 93
2023
Q1 		$720K Buy
12,321
+48
+0.4% +$2.89K 0.16% 89
2022
Q4 		$761K Buy
12,273
+153
+1% +$9.2K 0.18% 86
2022
Q3 		$685K Hold
12,120
– – 0.17% 86
2022
Q2 		$774K Buy
12,120
+48
+0.4% +$3.05K 0.19% 85
2022
Q1 		$782K Buy
12,072
+48
+0.4% +$3.04K 0.16% 86
2021
Q4 		$800K Buy
12,024
+102
+0.9% +$6.47K 0.16% 85
2021
Q3 		$728K Hold
11,922
– – 0.15% 85
2021
Q2 		$738K Buy
11,922
+90
+0.8% +$5.47K 0.15% 85
2021
Q1 		$701K Hold
11,832
– – 0.15% 86
2020
Q4 		$708K Buy
11,832
+36
+0.3% +$2.05K 0.17% 81
2020
Q3 		$643K Buy
11,796
+51
+0.4% +$2.75K 0.19% 81
2020
Q2 		$602K Buy
11,745
+75
+0.6% +$3.77K 0.19% 81
2020
Q1 		$523K Hold
11,670
– – 0.2% 79
2019
Q4 		$623K Sell
11,670
-2,517
-18% -$124K 0.19% 81
2019
Q3 		$661K Sell
14,187
-3,192
-18% -$153K 0.23% 77
2019
Q2 		$874K Sell
17,379
-1,761
-9% -$87.1K 0.31% 66
2019
Q1 		$982K Buy
19,140
+69
+0.4% +$3.43K 0.36% 62
2018
Q4 		$895K Buy
19,071
+96
+0.5% +$4.92K 0.37% 63
2018
Q3 		$1.06M Buy
18,975
+60
+0.3% +$3.28K 0.36% 62
2018
Q2 		$954K Hold
18,915
– – 0.33% 64
2018
Q1 		$930K Buy
18,915
+69
+0.4% +$3.54K 0.33% 63
2017
Q4 		$970K Buy
18,846
+96
+0.5% +$4.93K 0.35% 63
2017
Q3 		$977K Sell
18,750
-504
-3% -$25.9K 0.37% 64
2017
Q2 		$996K Hold
19,254
– – 0.39% 63
2017
Q1 		$969K Buy
19,254
+45
+0.2% +$2.23K 0.38% 61
2016
Q4 		$906K Buy
19,209
+87
+0.5% +$4.13K 0.37% 64
2016
Q3 		$953K Hold
19,122
– – 0.4% 64
2016
Q2 		$920K Sell
19,122
-549
-3% -$26.1K 0.4% 64
2016
Q1 		$898K Buy
19,671
+300
+2% +$14K 0.4% 63
2015
Q4 		$1.04M Buy
19,371
+48
+0.2% +$2.52K 0.47% 59
2015
Q3 		$953K Sell
19,323
-1,230
-6% -$70.5K 0.45% 56
2015
Q2 		$1.2M Buy
20,553
+33
+0.2% +$1.93K 0.54% 47
2015
Q1 		$1.18M Sell
20,520
-408
-2% -$22.3K 0.55% 47
2014
Q4 		$1.06M Buy
20,928
+1,239
+6% +$60.4K 0.53% 47
2014
Q3 		$921K Buy
19,689
+4,755
+32% +$215K 0.49% 48
2014
Q2 		$673K Buy
14,934
+30
+0.2% +$1.29K 0.36% 55
2014
Q1 		$629K Buy
14,904
+9
+0.1% +$377 0.36% 52
2013
Q4 		$586K Buy
14,895
+4,563
+44% +$171K 0.36% 49
2013
Q3 		$366K Buy
+10,332
New +$364K 0.24% 61

Other funds holding IHE

Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return
TD Asset Management
TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 57.61% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
IWS
Insight Wealth Strategies San Ramon, California $1.02B AUM 38% 1-Year Est. Return

Asset Management Group's IHE Position: Q2 2026 in Review

Asset Management Group increased its iShares US Pharmaceuticals ETF (IHE) stake by 0.31% in Q2 2026, buying an estimated $3.6K and bringing the position to 12,997 shares worth $1.29M. The position accounts for 0.19% of the portfolio, ranked #86.

Asset Management Group first reported a position in IHE in Q3 2013 and has held it in 52 quarters since. 209 funds tracked by Wall St. Rank hold IHE as of Q2 2026.

  • Asset Management Group held 12,997 shares of iShares US Pharmaceuticals ETF worth $1.29M as of Q2 2026.
  • Asset Management Group bought 40 iShares US Pharmaceuticals ETF shares in Q2 2026, an estimated $3.6K.
  • iShares US Pharmaceuticals ETF made up 0.19% of Asset Management Group's portfolio in Q2 2026, its #86 holding.
  • Asset Management Group first reported a position in iShares US Pharmaceuticals ETF in Q3 2013 and has held it in 52 quarters since.
  • 209 funds tracked by Wall St. Rank held iShares US Pharmaceuticals ETF as of Q2 2026.

Based on Asset Management Group's 13F filing for Q2 2026, filed 14 Aug 2026.